Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome

INTRODUCTION: Several endocrine manifestations have been described in patients with 22q11 deletion syndrome, including growth retardation, hypoparathyroidism, and thyroid disorders. This study aimed to characterize these abnormalities in a Colombian retrospective cohort of children with this conditi...

Full description

Bibliographic Details
Main Authors: Juan Lasprilla Tovar, Nora Alejandra Zuluaga, Adriana Carolina Forero Torres, Oscar Correa-Jimenez, Javier Mauricio Sierra
Format: Article
Language:English
Published: Galenos Yayincilik 2023-03-01
Series:JCRPE
Subjects:
Online Access:https://jcrpe.org/jvi.aspx?un=JCRPE-18291&volume=15&issue=1
_version_ 1811161489059348480
author Juan Lasprilla Tovar
Nora Alejandra Zuluaga
Adriana Carolina Forero Torres
Oscar Correa-Jimenez
Javier Mauricio Sierra
author_facet Juan Lasprilla Tovar
Nora Alejandra Zuluaga
Adriana Carolina Forero Torres
Oscar Correa-Jimenez
Javier Mauricio Sierra
author_sort Juan Lasprilla Tovar
collection DOAJ
description INTRODUCTION: Several endocrine manifestations have been described in patients with 22q11 deletion syndrome, including growth retardation, hypoparathyroidism, and thyroid disorders. This study aimed to characterize these abnormalities in a Colombian retrospective cohort of children with this condition. METHODS: A retrospective study comprising a cohort of children with 22q11 deletion syndrome in Medellín, Colombia followed up between 2011 and 2017 was conducted. RESULTS: Thirty-seven patients with a confirmed diagnosis of 22q11 deletion syndrome were included. 37.8% had some endocrinopathy, the most frequent being hypoparathyroidism (21.6%), followed by hypothyroidism (13.5%), hyperthyroidism (2.7%) and growth hormone deficiency (2.7%). There was wide heterogeneity in the clinical presentation, with late onset of severe hypocalcemia associated with seizure or precipitated in postoperative cardiac surgery, which highlights the importance of continuous follow-up as indicated by the guidelines. Short stature was mainly related to nutritional factors. Growth monitoring is required with the use of syndrome-specific charts and careful monitoring of the growth rate. DISCUSSION AND CONCLUSION: As previously reported, a significant proportion of patients with endocrine abnormalities were found in this cohort. This highlights that it is essential to carry out an adequate multidisciplinary follow-up, based on the specific clinical guidelines, in order to avoid serious complications such as convulsions due to hypocalcemia. It is important to track size with curves specific to the syndrome and analyze the growth rate.
first_indexed 2024-04-10T06:15:06Z
format Article
id doaj.art-5fcda2f551754c99b2322df3ed44b3e7
institution Directory Open Access Journal
issn 1308-5727
1308-5735
language English
last_indexed 2024-04-10T06:15:06Z
publishDate 2023-03-01
publisher Galenos Yayincilik
record_format Article
series JCRPE
spelling doaj.art-5fcda2f551754c99b2322df3ed44b3e72023-03-02T08:32:49ZengGalenos YayincilikJCRPE1308-57271308-57352023-03-01151162410.4274/jcrpe.galenos.2022.2022-4-12Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion SyndromeJuan Lasprilla Tovar0https://orcid.org/0000-0002-7165-0057Nora Alejandra Zuluaga1https://orcid.org/0000-0002-4199-3286Adriana Carolina Forero Torres2https://orcid.org/0000-0001-8722-8443Oscar Correa-Jimenez3https://orcid.org/0000-0001-6007-2821Javier Mauricio Sierra4https://orcid.org/0000-0002-0486-0417HOMI Fundacion Hospital Pediatrico la Misericordia, Pediatric Endocrinologist, Colombia, South AmericaHospital San Vicente Fundación and Associate Professor, Universidad de Antioquia, Pediatric Endocrinologist, Colombia, South AmericaHospital San Vicente Fundación and Associate Professor, Universidad de Antioquia, Pediatric Endocrinologist, Colombia, South AmericaUniversidad Nacional de Colombia, Pediatric Pulmonology and Immunology Research Group, Colombia, South AmericaUniversidad de Antioquia, Department of Pediatrics, Colombia, South AmericaINTRODUCTION: Several endocrine manifestations have been described in patients with 22q11 deletion syndrome, including growth retardation, hypoparathyroidism, and thyroid disorders. This study aimed to characterize these abnormalities in a Colombian retrospective cohort of children with this condition. METHODS: A retrospective study comprising a cohort of children with 22q11 deletion syndrome in Medellín, Colombia followed up between 2011 and 2017 was conducted. RESULTS: Thirty-seven patients with a confirmed diagnosis of 22q11 deletion syndrome were included. 37.8% had some endocrinopathy, the most frequent being hypoparathyroidism (21.6%), followed by hypothyroidism (13.5%), hyperthyroidism (2.7%) and growth hormone deficiency (2.7%). There was wide heterogeneity in the clinical presentation, with late onset of severe hypocalcemia associated with seizure or precipitated in postoperative cardiac surgery, which highlights the importance of continuous follow-up as indicated by the guidelines. Short stature was mainly related to nutritional factors. Growth monitoring is required with the use of syndrome-specific charts and careful monitoring of the growth rate. DISCUSSION AND CONCLUSION: As previously reported, a significant proportion of patients with endocrine abnormalities were found in this cohort. This highlights that it is essential to carry out an adequate multidisciplinary follow-up, based on the specific clinical guidelines, in order to avoid serious complications such as convulsions due to hypocalcemia. It is important to track size with curves specific to the syndrome and analyze the growth rate.https://jcrpe.org/jvi.aspx?un=JCRPE-18291&volume=15&issue=122q11 deletion syndromedigeorge syndromehypoparathyroidismhypothyroidismgrowth disordersendocrine system diseases
spellingShingle Juan Lasprilla Tovar
Nora Alejandra Zuluaga
Adriana Carolina Forero Torres
Oscar Correa-Jimenez
Javier Mauricio Sierra
Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome
JCRPE
22q11 deletion syndrome
digeorge syndrome
hypoparathyroidism
hypothyroidism
growth disorders
endocrine system diseases
title Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome
title_full Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome
title_fullStr Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome
title_full_unstemmed Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome
title_short Endocrine Abnormalities and Growth Characterization in Colombian Pediatric Patients with 22q11 Deletion Syndrome
title_sort endocrine abnormalities and growth characterization in colombian pediatric patients with 22q11 deletion syndrome
topic 22q11 deletion syndrome
digeorge syndrome
hypoparathyroidism
hypothyroidism
growth disorders
endocrine system diseases
url https://jcrpe.org/jvi.aspx?un=JCRPE-18291&volume=15&issue=1
work_keys_str_mv AT juanlasprillatovar endocrineabnormalitiesandgrowthcharacterizationincolombianpediatricpatientswith22q11deletionsyndrome
AT noraalejandrazuluaga endocrineabnormalitiesandgrowthcharacterizationincolombianpediatricpatientswith22q11deletionsyndrome
AT adrianacarolinaforerotorres endocrineabnormalitiesandgrowthcharacterizationincolombianpediatricpatientswith22q11deletionsyndrome
AT oscarcorreajimenez endocrineabnormalitiesandgrowthcharacterizationincolombianpediatricpatientswith22q11deletionsyndrome
AT javiermauriciosierra endocrineabnormalitiesandgrowthcharacterizationincolombianpediatricpatientswith22q11deletionsyndrome